Market data
Medical Conditions Disorders
Explore verified medical conditions disorders statistics and market research reports with sourced data and trend analysis.
Latest update:
Elif Demirci
Salmonella Statistics
Salmonella drives 51% of global foodborne diarrheal disease deaths tied to major pathogens, yet the detection and control picture shifts from a 0.8% carbapenem resistance signal in surveillance to reported poultry improvements cutting incidence by 25.0% and faster diagnostics that can deliver results in as little as 6 hours. See how contamination moves from broiler carcasses and pig slaughtering through egg systems and kitchen surfaces, then how sanitizing washes, UV-C, and regulated sampling targets can swing outcomes from millions of bacteria down to near non detectability.
Diabetes Statistics
Diabetes is far more than a lab result, from 14.8% of US pregnancies affected by diabetes to $327 billion in 2017 healthcare costs split between diagnosed and undiagnosed disease. You will also find why newer monitoring and drug trials are shifting outcomes, alongside the global toll of 6.7 million diabetes related deaths and what that means for life expectancy and treatment gaps.
Cardiac Arrest Statistics
Most out of hospital cardiac arrests happen at home, yet outcomes hinge on minute by minute action and shockable rhythms. Find the 2019 US survival to hospital discharge benchmark of 10.8% and the evidence behind why faster AED use, bystander CPR, and dispatcher assisted guidance can change survival odds when every extra minute quietly cuts them.
Aneurysm Statistics
Aneurysm numbers can look stable until you see how the latest stroke and death trends are shifting, and why size and location decide who gets hit hardest. If you want to understand the real-world risk behind the headlines, this page connects current statistics to the factors that change outcomes.
Uterine Fibroids Statistics
Heavy menstrual bleeding is the most common symptom, affecting millions of women with uterine fibroids, and ACOG estimates 25% of women ages 20 to 54 have them on 2003 to 2004 ultrasound data from NHANES. Yet the burden goes far beyond periods, with costs and care needs that drive far more physician visits and surgeries, including 200,000 to 300,000 hysterectomies and myomectomies each year in the US, and a substantial share of women who are asymptomatic until symptoms emerge.
Gender Reassignment Surgery Statistics
See what the latest 2025 and 2026 Gender Reassignment Surgery figures reveal about where care is heading and how outcomes differ when access and treatment pathways change. The page turns raw counts into a clear contrast between expectation and reality so you can understand the trends that matter most for planning and policy.
Color Blindness Statistics
Blue yellow color vision deficiency affects just 0.01% to 0.02% of people yet nearly every interface still relies on color alone, even though multimodal texture and shape cues can cut errors and lift accuracy by 18%. The page brings together prevalence research and performance metrics from tests and real design settings to show what works, including accessibility guidance like WCAG 2.2 and market and tech adoption signals through a $1.3 billion to $2.0 billion testing market projection by 2030.
Pediatric Cancer Statistics
Pediatric cancer isn’t just rare, it’s reshaping survival expectations as newer figures show more children are living beyond diagnosis than ever before. See which cancers drive the highest incidence and which outcomes have shifted most, so you can separate hopeful trends from the parts that still demand urgency.
Muscular Dystrophy Statistics
One in 3,300 people worldwide are estimated to live with muscular dystrophy, yet Duchenne drives much of the urgency with up to 90% of patients facing respiratory complications, median loss of ambulation at about 12 years, and cardiac and breathing risks that can be delayed by early treatment. This page also connects the clinical reality to what is happening now, from the global gene therapy market reaching $2.2 billion in 2022 to the 2023 rare disease diagnostics and therapeutics spend, plus FDA accelerated and full approvals that changed DMD care timelines.
Endometrial Cancer Statistics
A 2025 look at endometrial cancer statistics highlights how many new cases are diagnosed each year and why incidence and outcomes can diverge sharply across groups. If you thought the biggest risk was just age, these numbers show a more complicated picture and make the latest trends impossible to ignore.
Blighted Ovum Statistics
Find out why Blighted Ovum has become a standout line in 2026 fertility statistics, and how the most recent numbers are reshaping what people expect after an early ultrasound. The page contrasts rising detection and diagnosis patterns with the reality of how often these pregnancies end, so you can see the gap between “what the scan suggests” and “what the timeline usually becomes.”
Celiac Disease Statistics
See how case finding and tTG serology in high risk groups raise detection, while only 10% to 15% struggle to improve on a gluten free diet, leaving lingering symptoms and anemia. Track prevalence from 1% in the US and 2% in people with type 1 diabetes to the extra risks often missed at diagnosis, including fractures, EATL, and autoimmune comorbidities.
Heat Stroke Statistics
Heat stroke can turn deadly fast, and the latest Heat Stroke statistics make that urgency impossible to ignore. From the jump in emergency cases during peak heat to the people most likely to be hit, this page pinpoints the patterns you can actually use when it matters.
Wilsons Disease Statistics
Wilson disease affects about 1 in 30,000 people, yet among unexplained pediatric liver disease it accounts for roughly 1 to 2 percent, and in acute liver failure it drives about 2 to 3 percent of cases. Learn why the timeline matters too, with a median delay to diagnosis of 2.5 years and outcomes improving substantially when treatment starts early, backed by global prevalence estimated at about 3.3 per million and incidence at about 0.6 per million person years from a 2019 systematic review.
Hepatocellular Carcinoma Statistics
With about 830,000 global HCC deaths in 2020 and cirrhosis driving risk where many patients progress at a few percent per year, the page translates survival relevant numbers into a clear view of who needs surveillance and why it matters. It connects the biggest modifiable causes like HCV, alcohol, smoking, diabetes, and obesity to quantified risk jumps, then pairs that with modern diagnosis and treatment benchmarks such as 6 month ultrasound strategies and current therapy trial outcomes like atezolizumab plus bevacizumab in IMbrave150.
Women Hiv Statistics
With 29.8 million people living with HIV worldwide in 2023 and women and girls making up a majority in high burden settings, Women Hiv statistics cuts through the headline to show exactly how gender shapes infection, diagnosis, treatment and deaths. You will see the tension between progress and gap, like 86% of women on ART in 2023 versus the persistent uneven odds of knowing status and staying in care, including a 1.6 times higher likelihood of women than men living with HIV in sub-Saharan Africa.
Hiv Transmission Statistics
See how HIV transmission patterns shifted in 2025 and what that means for where infections are most likely to spread next. The page brings the latest figures into sharp focus, so you can compare hotspots against progress rather than relying on outdated assumptions.
Cancer Treatment Statistics
Cancer burden is rising fast, with about 20.0 million new cases and 9.7 million deaths worldwide in 2021, while treatment outcomes vary sharply by cancer type and stage. This page puts the biggest causes and survival gaps side by side, from prostate and lung incidence to the stark 5-year survival differences for lung, colorectal, and breast cancer, so you can see where care is advancing and where it still lags.
Malaria Statistics
2025 malaria data shows how far progress has come and how quickly gains can stall, with cases and deaths revealing a sharp split between where transmission is easing and where it is still tightening its grip. Use these up to date figures to understand which regions and intervention gaps matter most right now.
Breast Cancer Early Detection Statistics
Mammography screening is tied to a 29% reduction in breast cancer mortality for women aged 40 to 74, yet only 12.2% of US women aged 50 to 74 reported a mammogram in the past 2 years, leaving a real gap between evidence and access. See how modern tools like digital breast tomosynthesis, MRI, and ultrasound shift performance and costs, from 3.2% higher cancer detection to Medicare claims showing 1.3 million screened women in 2020.